Skip to content

Straumann BLX Implant System SLA Roxolid BL (REF 061.4506)Recalls & reported problems

Institut Straumann AG · BLX Implant, Ø 3.75mm RB, SLA 6mm, Roxolid · Class 2 · Implant

All models of Straumann BLX Implant System (60)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann BLX dental implant is placed into bone. Its 479 adverse event reports mostly describe the implant failing to bond with the bone, with many also mentioning scar tissue, pain, and infection. There are 479 injuries and no deaths. Reports rose from 106 in the prior 12 months to 152 in the last 12. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
490
Deaths reported
0
Injuries reported
490
Recalls naming it
0

Summary

The FDA's MAUDE database contains 490 adverse event reports that list this exact device (DI 07630031743435), received between Sep 6, 2021 and Sep 17, 2026 — classified as 490 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (388 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 10 reportsDec 2023: 9 reportsJan 2024: 11 reportsFeb 2024: 3 reportsMar 2024: 4 reportsApr 2024: 12 reportsMay 2024: 10 reportsJun 2024: 4 reportsJul 2024: 13 reportsAug 2024: 9 reportsSep 2024: 13 reportsOct 2024: 10 reportsNov 2024: 12 reportsDec 2024: 8 reportsJan 2025: 9 reportsFeb 2025: 11 reportsMar 2025: 6 reportsApr 2025: 6 reportsMay 2025: 0 reportsJun 2025: 26 reportsJul 2025: 13 reportsAug 2025: 7 reportsSep 2025: 3 reportsOct 2025: 5 reportsNov 2025: 29 reportsDec 2025: 19 reportsJan 2026: 9 reportsFeb 2026: 10 reportsMar 2026: 33 reportsApr 2026: 9 reportsMay 2026: 9 reportsJun 2026: 6 reportsJul 2026: 22 reportsAug 2026: 5 reportsSep 2026: 12 reportsOct 2026: 0 reports20242025202633
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate388
  • Loss of Osseointegration64
  • Adverse Event Without Identified Device or Use Problem32
  • Difficult to Insert5
  • Fracture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions296
  • Fibrosis123
  • Pain63
  • Unspecified Infection53
  • Inflammation29
  • Hemorrhage/Blood Loss/Bleeding22
  • Hyperresponsive to stimuli14
  • Swelling/ Edema14

Recent adverse event reports

The 25 most recent of 490 reports, in the reporter's own words as published by the FDA.

  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50807115 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 13. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50806362 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50760829 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50760827 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50760825 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50760824 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50760820 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50760818 ↗
  • InjurySep 11, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2025 in FDI 36. On (b)(6) 2026, loss of osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50738416 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Pain; Swelling/ Edema

    MAUDE report 50719100 ↗
  • InjurySep 7, 2026Loss of Osseointegration

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654732 ↗
  • InjurySep 7, 2026Loss of Osseointegration

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50653859 ↗
  • InjuryAug 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6)2026 in the patient's mouth. On (b)(6)2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50480794 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50414441 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in the patient's mouth. On (b)(6) 2026, non-osseointegration was verified. No product was returned to the manufacturer. At the event the patient experienced: Mobility and Inflammation. No further patient complications were reported.

    Patient problems: Fibrosis; Inflammation

    MAUDE report 50282395 ↗
  • InjuryAug 3, 2026Loss of Osseointegration

    Patient problems: Inflammation

    MAUDE report 50119043 ↗
  • InjuryAug 3, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in FDI 46. On (B)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Pain. No further patient complications were reported.

    Patient problems: Pain

    MAUDE report 50118973 ↗
  • InjuryJul 31, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 37. On (b)(6) 2026, loss of osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Pain and Inflammation. No further patient complications were reported.

    Patient problems: Inflammation; Pain

    MAUDE report 50103052 ↗
  • InjuryJul 27, 2026Loss of Osseointegration

    The clinician reports the implant was inserted 2023-(b)(6) in ADA 30. On 2026-(b)(6), loss of osseointegration was verified. Patient presented with inadequate bone quality/quantity. The device was forwarded to the manufacturer. At the event the patient experienced: Peri-implantitis and Mobility. No further patient complications were reported.

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 50041002 ↗
  • InjuryJul 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2025 in the patient's mouth. On (B)(6) 2026, non-osseointegration was verified. No product was returned to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50040516 ↗
  • InjuryJul 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in the patient's mouth. On (b)(6) 2026, non-osseointegration was verified. No product was returned to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50040447 ↗
  • InjuryJul 27, 2026Loss of Osseointegration

    The clinician reports the implant was inserted 2023 (b)(6) in ADA 30. On 2026 (b)(6), loss of osseointegration was verified. Patient presented with inadequate bone quality/quantity. The device was forwarded to the manufacturer. At the event the patient experienced: Peri-implantitis and Mobility. No further patient complications were reported.

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 50039562 ↗
  • InjuryJul 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2025 in FDI 24. On (B)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50023092 ↗
  • InjuryJul 16, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED ON (B)(6) 2026 IN THE PATIENT'S MOUTH. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO REPORTED PATIENT INJURIES OR COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25844070 ↗
  • InjuryJul 13, 2026Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2026 IN ADA 3. DETAILS OF SURGERY: PRIMARY STABILITY NOT ACHIEVED AND IMPLANT SURFACE NOT COMPLETELY COVERED WITH BONE. ON (B)(6) 2026, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO REPORTED PATIENT INJURIES OR COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25802296 ↗

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page